Investing in local, often neglected brands has propelled Stada up the rankings of Europe’s leading OTC players. The Germany-based company believes it can displace Bayer as Europe’s number-three OTC supplier in the not too distant future with its Consumer Healthcare sales on an upward trajectory across the region.
But Stada is not stopping there
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?